Lisinopril (CAS 76547-98-3) ACE Inhibitor API

Lisinopril (CAS 76547-98-3) is a high-purity ACE inhibitor API with a targeted cardiovascular regulatory mechanism. It blocks the conversion of angiotensin I to angiotensin II, dilating blood vessels and reducing peripheral vascular resistance to lower blood pressure, while also protecting cardiac and renal function in patients with hypertension and heart failure. Its refined crystalline form ensures consistent bioactivity and low impurity profiles, making it a reliable active ingredient for cardiovascular pharmaceutical R&D.

Tailored for pharmaceutical manufacturers and cardiology research institutions, this product adheres to strict international quality and regulatory standards. It addresses the core demand for antihypertensive raw materials, supporting the development of formulations for essential hypertension and congestive heart failure research. Its stable chemical structure guarantees extended shelf life, facilitating flexible formulation design for oral preparations and clinical trial applications.